Form 4: LifeStance Health Group Director Robert Bessler Reports Stock Sales

Robert Bessler, a director of LifeStance Health Group, reported the sale of common stock through indirect holdings, as detailed in a recent SEC Form 4 filing.

Summary

• Robert Bessler, a director of LifeStance Health Group, filed a Form 4 with the SEC.
• The filing reports the sale of LifeStance Health Group common stock on April 8 and April 9, 2025.
• The sales were executed indirectly through Vitthal LLC and Shama LLC.
• On April 8, 2025, 7 shares were sold at $7 per share through both Vitthal LLC and Shama LLC.
• On April 9, 2025, 2,450 shares were sold at a weighted average price of $7.01 per share through both Vitthal LLC and Shama LLC.
• Following these transactions, Bessler indirectly owns 1,421,990 shares through Vitthal LLC and 1,538,790 shares through Shama LLC.
• Bessler also indirectly owns 36,363 shares through Alpine Glow Capital.
• Bessler disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a report of stock sales, which doesn't inherently indicate positive or negative sentiment. The director disclaims beneficial ownership, further neutralizing the sentiment.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's future prospects. However, it's important to consider that these sales can be for various personal financial reasons and don't always reflect a negative outlook on the company.

Stakeholder Impact

• Shareholders may react to the reported stock sales, potentially influencing the stock price.

Key Dates

Keywords

Form 4, LifeStance Health Group, LFST, Robert Bessler, Stock Sale, Insider Trading, Vitthal LLC, Shama LLC, Alpine Glow Capital